Patent Assignment
Reel/Frame 029339/0669
Security Agreement
Recorded: 2012-11-20
Pages: 23
Assignors
CUBIST PHARMACEUTICALS, INC.
Executed: 2012-11-20
ADOLOR CORPORATION
Executed: 2012-11-20
CALIXA THERAPEUTICS, INC.
Executed: 2012-11-20
CUBIST PHARMACEUTICALS HOLDINGS, INC.
Executed: 2012-11-20
CUBIST PHARMACEUTICALS U.S.
Executed: 2012-11-20
Assignee
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
20 KING STREET WEST, 4TH FLOOR, TORONTO, ONTARIO, M5H1C4, CANADA
Covered Properties
(108)
Derivatives of a-21978C Cyclic Peptides
Patent:
4,537,717 →
Application:
06/652,695 →
Process for Producing a-21978C Derivatives
Patent:
4,885,243 →
Application:
06/773,762 →
Sesquiterpenes, Their Preparation and Their Use as Inhibitors Acting on the Gaba-Benzodiazepine Receptor
Patent:
5,565,486 →
Application:
08/464,737 →
Kappa Agonist Compounds and Pharmaceutical Formulations Thereof
Patent:
5,646,151 →
Application:
08/612,680 →
Methods for Generating and Screening Novel Metabolic Pathways
Patent:
5,824,485 →
Application:
08/639,255 →
Aminoacyl Adenylate Mimics as Novel Antimicrobial and Antiparasitic Agents
Patent:
5,726,195 →
Application:
08/683,809 →
Peripherally Active Anti-Hyperalgesic Opiates
Patent:
5,994,372 →
Application:
08/712,881 →
Methods for Generating and Screening Novel Metabolic Pathways
Patent:
5,783,431 →
Application:
08/738,944 →
Kappa Agonist Compounds and Pharmaceutical Formulations Thereof
Patent:
5,688,955 →
Application:
08/796,078 →
Spray Formulations of Antihyperalgesic Opiates and Method of Treating Topical Hyperalgesic Conditions Therewith
Patent:
5,811,078 →
Application:
08/818,559 →
Method of Treatment of Migraine
Patent:
5,855,907 →
Application:
08/828,144 →
Enterococcal Aminoacyl-Trna Synthetase Proteins, Nucleic Acids and Strains Comprising Same
Patent:
6,221,640 →
Application:
08/855,910 →
Method for Isolation of Biosysntheis Genes for Bioactive Molecules
Patent:
6,297,007 →
Application:
08/861,774 →
Film-Forming Compositions of Antihyperalgesic Opiates and Mehtod of Treating Hyperalgesic and Pruritic Conditions Therewith
Patent:
5,888,494 →
Application:
08/891,924 →
Peripherally Acting Anti-Pruritic Opiates
Patent:
5,849,762 →
Application:
08/892,194 →
Spray Formulations of Antihyperalgesic Opiates and Method of Treating Topical Hyperalgesic Conditions and Pruritus Therewith
Patent:
5,798,093 →
Application:
08/892,389 →
Kappa Agonist Anti-Pruritic Pharmaceutical Formulations and Method of Treating Pruritus Therewith
Patent:
5,869,521 →
Application:
09/064,695 →
Kappa Agonist Compounds and Pharmaceutical Formulations Thereof
Patent:
6,303,611 →
Application:
09/150,369 →
Method for Inhibiting Eukaryotic Protein Kinases
Patent:
6,132,984 →
Application:
09/174,261 →
Method for Inhibiting Eukaryotic Protein Kinases
Patent:
6,319,898 →
Application:
09/174,263 →
Method for Identifying Validated Target and Assay Combinations for Drug Development
Patent:
6,846,625 →
Application:
09/227,687 →
Methods for Generating and Screening Novel Metabolic Pathways
Patent:
6,242,211 →
Application:
09/263,352 →
Regulable Gene Expression in Gram-Positive Bacteria
Patent:
6,436,694 →
Application:
09/291,874 →
Method for Identifying Validated Target and Assay Combinations for Drug Development
Patent:
6,475,726 →
Application:
09/344,783 →
Kappa Agonist Compounds Pharmaceutical Formulations and Method of Prevention and Treatment of Pruritus Therewith
Patent:
6,239,154 →
Application:
09/372,191 →
Peripherally Active Anti-Hyperalgesic Opiates
Patent:
6,573,282 →
Application:
09/374,634 →
Novel Heterocycles as Antimicrobial Agents
Patent:
6,153,645 →
Application:
09/393,505 →
Methods for Administration of Antibiotics
Patent:
6,468,967 →
Application:
09/406,568 →
Kappa Agonist Compounds, Pharmaceutical Formulations and Method of Prevention and Treatment of Pruritus Therewith
Patent:
6,180,623 →
Application:
09/436,057 →
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
Patent:
6,156,769 →
Application:
09/488,420 →
Anhydro-And Isomer-a-21978C Cyclic Peptides
Patent:
39,071 →
Application:
09/547,357 →
Novel Methods and Compositions Involving Opioids and Antagonists Thereof
Novel Methods for the Treatment and Prevention of Ileus
High Purity Lipopeptides, Lipopeptide Micelles and Processes for Preparing Same
Patent:
6,696,412 →
Application:
09/735,191 →
Novel Lipopeptides as Antibacterial Agents
Novel Lipopeptides as Antibacterial Agents
Novel Lipopeptides as Antibacterial Agents
Delta Agonist Analgesics
Kappa Agonist Compounds and Pharmaceutical Formulations Thereof
Patent:
38,133 →
Application:
10/066,909 →
Methods for Administration of Antibiotics
Methods for the Treatment or Inhibition of Ileus
Lipopeptide Stereoisomers, Methods for Preparing Same, and Useful Intermediates
Novel Processes for the Preparation of Peripheral Opioid Antagonist Compounds and Intermediates Thereto
Substituted Piperidine Compounds
Kappa Agonist Compounds, Pharmaceutical Formulations and Method of Prevention and Treatment of Pruritus Therewith
Sulfonylamino Phenylacetamide Derivatives and Methods of Their Use
Substituted Piperidine Compounds and Methods of Their Use
Fused Bicyclic Carboxamide Derivatives and Methods of Their Use
Amide Derivatives and Methods of Their Use
Substituted Piperidine Compounds and Methods of Their Use
Novel Processes for the Preparation of Peripheral Opioid Antagonist Compounds and Intermediates Thereto
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Methods of preventing and treating gastrointestinal dysfunction
Novel Lipopeptides as Antibacterial Agents
Compositions Containing Opioid Antagonists
Substituted Piperidine Compounds and Methods of Their Use
Phenyl Derivatives and Methods of Use
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Substituted Piperidine Compounds and Methods of Their Use
Solid Dispersions of Opioid Antagonists
Novel Opioid Antagonists
Sulfamoyl Benzamides and Methods of Their Use
Compositions containing opioid antagonists
Application:
11/582,681 →
Publication:
US 2007/0092576
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
High Purity Lipopeptides
Methods for Enhancing Cognitive Function
Application:
11/851,995 →
Publication:
US 2008/0119452
Therapeutic Compositions
Daptomycin for the Treatment of Biofilm and Catheter Salvage
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Compositions of (-)-E-10-Oh-Nt and Methods for Their Synthesis and Use
Application:
12/107,742 →
Publication:
US 2008/0275131
Substituted Piperidine Compounds and Methods of Their Use
Methods for Preparing Purified Lipopeptides
(-)-Beloxepin and Methods for Its Synthesis and Use
Application:
12/388,903 →
Publication:
US 2009/0233957
(+)-Beloxepin and Methods for Its Synthesis and Use
Application:
12/388,950 →
Publication:
US 2009/0233958
Novel Opioid Antagonists
Methods for Delivering a Drug to a Hospital Patient for Short-Term Use While Minimizing Long-Term Use of the Drug
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Novel Antibacterial Agents for the Treatment of Gram Positive Infections
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Beloxepin and Analogs for the Treatment of Pain
Substituted Piperidinylpropanoic Acid Compounds and Methods of Their Use
Application:
12/795,095 →
Publication:
US 2010/0311782
Use of an Opioid Receptor Antagonist for the Treatment or Prevention of Gastrointestinal Tract Disorders
Application:
12/884,985 →
Publication:
US 2011/0071163
High Purity Lipopeptides
Substituted Piperidine Compounds and Methods of Their Use
Substituted Piperidine Compounds and Methods of Their Use
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Application:
13/097,940 →
Publication:
US 2011/0218186
Beloxepin and Analogs for the Treatment of Pain
Application:
13/252,982 →
Publication:
US 2012/0108623
Spirocyclic Heterocyclic Derivatives and Methods of Their Use
Application:
13/274,616 →
Publication:
US 2012/0165356
High Purity Lipopeptides
Compositions of (-)-E-10-OH-NT and Methods for Their Synthesis and Use
Application:
13/427,744 →
Publication:
US 2012/0178815
Compositions Containing Opioid Antagonists
Novel Opioid Antagonists
CB-183,315 Compositions and Related Methods
Application:
13/481,009 →
Publication:
US 2013/0109633
Lipopeptide Compositions and Related Methods
Methods for Delivering a Drug to a Hospital Patient for Short-Term Use While Minimizing Long-Term Use of the Drug
Inhibiting Transient Receptor Potential Ion Channel TRPA1
Application:
13/571,288 →
Methods for Treating Intrapulmonary Infections
Application:
13/607,138 →
Publication:
US 2013/0065874
Tazobactam Arginine Compositions
Patent:
8,476,425 →
Application:
13/628,742 →
Beta-Lactamase Inhibitors
Application:
61/618,119 →
Beta-Lactamase Inhibitors
Application:
61/618,127 →
Beta-Lactamase Inhibitors
Application:
61/618,131 →
Beta-Lactamase Inhibitors
Application:
61/618,136 →
Methods for Treating Intrapulmonary Infections
Application:
61/657,386 →
Compositions with Increased Stability for Inhibiting Transient Receptor Potential Ion Channel TRPA1
Application:
61/681,506 →
Inhibiting Transient Receptor Potential Ion Channel TRPA1
Application:
61/681,571 →
Cephalosporin Compound
Application:
61/698,241 →
Tazobactam Arginine Antibiotic Compositions
Application:
61/706,399 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment
Jul 9, 2015
From: ADOLOR CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036046/0153 →
Release of Security Interest
Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: CALIXA THERAPEUTICS, INC.; ADOLOR CORPORATION; CUBIST PHARMACEUTICALS, INC.
Reel/Frame 036180/0070 →
Change of Name
Aug 5, 2015
From: CUBIST PHARMACEUTICALS, INC.
To: CUBIST PHARMACEUTICALS LLC
Reel/Frame 036283/0189 →
Nunc Pro Tunc Assignment
Aug 6, 2015
From: CUBIST PHARMACEUTICALS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036268/0626 →